|

AUD/USD: Bears attack 0.6400 as trade war fears spread faster

  • AUD/USD stays on the back foot around the one-week low.
  • US President Trump, Secretary of State Mike Pompeo add fuel to the US-China trade war concerns.
  • Gilead’s Remdesivir will be available to the coronavirus patients this week.
  • Australia’s TD Securities Inflation, Building Permits and ANZ Job Advertisements will decorate the calendar.

AUD/USD drops further towards 0.6400, currently near 0.6406, after flashing the gap-down weekly opening to 0.6413 at the start of Monday’s Asian session. In addition to the coronavirus (COVID-19), the US-China trade war fears have been the latest catalyst weighing on the market’s risk-tone sentiment.

Read: What you need to know as markets open: Pompeo and Trump ratcheted up US and China tensions

US-China fights back in motion amid tough times…

The US and China fail to keep the peace for long and jostle even amid the global crisis triggered through the coronavirus (COVID-19). US President Donald Trump initially diverted the allegations of mishandling the virus outbreak to trade deal with China. However, his recent comments were severe as they suggest an intentional act of hiding virus facts and Wuhan’s laboratory being the epicenter of the outbreak.

Also joining the show, while following the footsteps of President Trump, US Secretary of State Mike Pompeo said on ABC’s This Week, “We can confirm that the Chinese Communist Party did all that it could to make sure that the world didn't learn in a timely fashion about what was taking place.”

It should also be noted that the comments from the US policymakers are likely to be backed by the intelligence report, as per the AP, which in turn could magnify the drama.

On the other hand, Chinese news didn’t avail Friday’s off to criticize US diplomats but failed to provide any strong measures to turn down the allegations.

Also weighing on the risk-tone could be the news from Axios suggesting that the US Republican Senate Conference want to wait before passing another coronavirus stimulus package.

Not everything is negative. The positive news comes from Gilead Science where the CEO announced to donate all the supplies of the much-championed drug to combat the pandemic. The CNBC mentioned that Gilead’s Remdesivir will be available to the parents this week.

Other than the US-China trade war fears, weakness in global economics, as well as downbeat performance of Wall Street, also portrayed the risk-off sentiment on Friday.

Moving on, Aussie traders will have second-tier Inflation, housing and job numbers to take intermediate clues from. TD Securities Inflation, up for publishing at 01:00 GMT, becomes the first one to watch. The early inflation gauge will have to cross 1.5% YoY and 0.2% MoM figures for March to turn down the dovish calls for April month RBA. Following that, expected declines in March month Building Permits to -15% from 19.9% prior, coupled with ANZ Job Advertisements, prior -10.3%, could also direct near-term Aussie moves.

Technical analysis

A daily closing below the monthly ascending trend line, currently around 0.6410, becomes necessary for the bears to enter and target 0.6340 mark comprising 21-day SMA. Until then, the pair’s another attempt to challenge 100-day SMA, near 0.6565 now, can’t be ruled out.

Additional important levels

Overview
Today last price0.6418
Today Daily Change0.0000
Today Daily Change %0.00
Today daily open0.6418
 
Trends
Daily SMA200.6357
Daily SMA500.6297
Daily SMA1000.6562
Daily SMA2000.6684
 
Levels
Previous Daily High0.6513
Previous Daily Low0.6409
Previous Weekly High0.657
Previous Weekly Low0.6382
Previous Monthly High0.657
Previous Monthly Low0.598
Daily Fibonacci 38.2%0.6449
Daily Fibonacci 61.8%0.6473
Daily Pivot Point S10.6381
Daily Pivot Point S20.6343
Daily Pivot Point S30.6277
Daily Pivot Point R10.6484
Daily Pivot Point R20.655
Daily Pivot Point R30.6588

Author

Anil Panchal

Anil Panchal

FXStreet

Anil Panchal has nearly 15 years of experience in tracking financial markets. With a keen interest in macroeconomics, Anil aptly tracks global news/updates and stays well-informed about the global financial moves and their implications.

More from Anil Panchal
Share:

Editor's Picks

EUR/USD trims gains, back below 1.1800

EUR/USD now loses some upside momentum, returning to the area below the 1.1800 support as the Greenback manages to regain some composure following the SCOTUS-led pullback earlier in the session.

GBP/USD off highs, recedes to the sub-1.3500 area

Following earlier highs north of 1.3500 the figure, GBP/USD now faces some renewed downside pressure, revisiting the 1.3490 zone as the US Dollar manages to regain some upside impulse in the latter part of the NA session on Friday.

Gold climbs to weekly tops, approaches $5,100/oz

Gold keeps the bid tone well in place at the end of the week, now hitting fresh weekly highs and retargeting the key $5,100 mark per troy ounce. The move higher in the yellow metal comes in response to ongoing geopolitical tensions in the Middle East and modest losses in the US Dollar.

Crypto Today: Bitcoin, Ethereum, XRP rebound as risk appetite improves

Bitcoin rises marginally, nearing the immediate resistance of $68,000 at the time of writing on Friday. Major altcoins, including Ethereum and Ripple, hold key support levels as bulls aim to maintain marginal intraday gains.

Week ahead – Markets brace for heightened volatility as event risk dominates

Dollar strength dominates markets as risk appetite remains subdued. A Supreme Court ruling, geopolitics and Fed developments are in focus. Pivotal Nvidia earnings on Wednesday as investors question tech sector weakness.

Ripple bulls defend key support amid waning retail demand and ETF inflows

XRP ticks up above $1.40 support, but waning retail demand suggests caution. XRP attracts $4 million in spot ETF inflows on Thursday, signaling renewed institutional investor interest.